Oppenheimer & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,163
Closed -$397K 1609
2021
Q2
$397K Buy
2,163
+57
+3% +$10.5K 0.01% 1123
2021
Q1
$322K Sell
2,106
-42
-2% -$6.42K 0.01% 1142
2020
Q4
$336K Buy
2,148
+100
+5% +$15.6K 0.01% 1048
2020
Q3
$234K Sell
2,048
-12
-0.6% -$1.37K 0.01% 1097
2020
Q2
$231K Sell
2,060
-1,691
-45% -$190K 0.01% 1061
2020
Q1
$337K Sell
3,751
-4,415
-54% -$397K 0.01% 866
2019
Q4
$883K Sell
8,166
-6,976
-46% -$754K 0.02% 664
2019
Q3
$1.48M Sell
15,142
-929
-6% -$91K 0.04% 481
2019
Q2
$2.11M Sell
16,071
-287
-2% -$37.6K 0.06% 385
2019
Q1
$2.21M Buy
16,358
+1,258
+8% +$170K 0.06% 361
2018
Q4
$1.47M Buy
15,100
+6,896
+84% +$671K 0.05% 410
2018
Q3
$1.14M Buy
8,204
+537
+7% +$74.6K 0.03% 562
2018
Q2
$952K Sell
7,667
-345
-4% -$42.8K 0.03% 614
2018
Q1
$893K Buy
8,012
+2,158
+37% +$241K 0.02% 649
2017
Q4
$700K Buy
5,854
+1,293
+28% +$155K 0.02% 738
2017
Q3
$640K Buy
4,561
+383
+9% +$53.7K 0.02% 762
2017
Q2
$508K Buy
+4,178
New +$508K 0.01% 826
2016
Q2
Sell
-2,480
Closed -$345K 1316
2016
Q1
$345K Sell
2,480
-797
-24% -$111K 0.01% 886
2015
Q4
$625K Sell
3,277
-569
-15% -$109K 0.02% 698
2015
Q3
$601K Buy
3,846
+10
+0.3% +$1.56K 0.02% 743
2015
Q2
$693K Sell
3,836
-819
-18% -$148K 0.02% 743
2015
Q1
$807K Sell
4,655
-553
-11% -$95.9K 0.02% 703
2014
Q4
$964K Sell
5,208
-1,943
-27% -$360K 0.03% 617
2014
Q3
$1.19M Sell
7,151
-1,666
-19% -$276K 0.04% 550
2014
Q2
$1.38M Sell
8,817
-1,626
-16% -$254K 0.04% 497
2014
Q1
$1.59M Buy
10,443
+535
+5% +$81.4K 0.05% 445
2013
Q4
$1.32M Buy
9,908
+3,577
+56% +$475K 0.04% 476
2013
Q3
$736K Buy
6,331
+3,048
+93% +$354K 0.03% 632
2013
Q2
$303K Buy
+3,283
New +$303K 0.01% 925